What are the major opportunities in the Angina Pectoris Drugs market? What are the strategies for the Angina Pectoris Drugs market?

For detailed insights on the major opportunities and strategies in the Angina Pectoris Drugs market, Read More

How does the Angina Pectoris Drugs market relate to the overall economy and other similar markets?

For detailed insights on Angina Pectoris Drugs's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Angina Pectoris Drugs industry?

For detailed insights on the mergers and acquisitions in the Angina Pectoris Drugs industry, Read More

What are the key dynamics influencing the Angina Pectoris Drugs market growth? SWOT analysis of the Angina Pectoris Drugs market.

For detailed insights on the key dynamics influencing the Angina Pectoris Drugs market growth and SWOT analysis of the Angina Pectoris Drugs industry, Read More

Angina Pectoris Drugs Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Angina Pectoris Drugs Market Report 2026

Name: Angina Pectoris Drugs Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drugs (Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins), By Indication (Stable Angina, Unstable Angina, Prinzmetal’s Angina), By Route of Administration (Oral, Parenteral, Transdermal, Other Route Of Administrations), By End User (Hospitals, Homecare, Specialty Clinics, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Angina Pectoris Drugs Market Overview

• Angina Pectoris Drugs market size has reached to $12.88 billion in 2025

• Expected to grow to $17.67 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%

• Growth Driver: Surging Prevalence Of Cardiovascular Diseases Propels Growth In The Angina Pectoris Drug Market

• Market Trend: Hikma Pharmaceuticals Unveils Labetalol Hydrochloride Injection, Usp, Marking A Milestone In Angina Pectoris Drug Market

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Angina Pectoris Drugs Market?

Angina pectoris drugs are medications used to treat angina pectoris, a medical illness that causes chest pain or discomfort when a portion of the heart does not receive enough blood and oxygen. Angina pectoris drugs treat chest pain or discomfort due to coronary heart disease.

The main drugs of angina pectoris drugs are nitrates, antiplatelet agents, beta-adrenergic blocking agents, calcium channel blockers, anti-ischemic agents, statins, antihypertensive agents, and other drugs. Nitrates and nitrites are nitrogen and oxygen atom-containing chemicals. Nitrates are frequently used to treat angina pectoris, a condition that involves chest pain or discomfort caused by decreased blood supply to the heart. The indications include stable angina, unstable angina, and prinzmetal’s angina. The angina pectoris drugs are administered via oral, parenteral, transdermal, other route of administrations that are used by hospitals, homecare, specialty clinics, other end users.

Angina Pectoris Drugs Market Global Report 2026 Market Report bar graph

What Is The Angina Pectoris Drugs Market Size and Share 2026?

The angina pectoris drugs market size has grown strongly in recent years. It will grow from $12.88 billion in 2025 to $13.63 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing prevalence of coronary heart disease, rising awareness of angina symptoms, introduction of beta-blockers, expansion of hospital infrastructure, growing adoption of calcium channel blockers.

What Is The Angina Pectoris Drugs Market Growth Forecast?

The angina pectoris drugs market size is expected to see strong growth in the next few years. It will grow to $17.67 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to advancements in precision medicine, growth of wearable cardiac monitoring devices, rising demand for combination therapies, increased investment in r&d for anti-ischemic agents, telehealth integration in cardiac care. Major trends in the forecast period include personalized angina management, minimally invasive drug delivery systems, fixed-dose combination therapies, growing geriatric patient population, telemedicine and remote cardiac monitoring.

Book your 30 minutes free consultation with our research experts

Global Angina Pectoris Drugs Market Segmentation

1) By Drugs: Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins

2) By Indication: Stable Angina, Unstable Angina, Prinzmetal’s Angina

3) By Route of Administration: Oral, Parenteral, Transdermal, Other Route Of Administrations

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Nitrates: Short-Acting Nitrates, Long-Acting Nitrates

2) By Antiplatelet Agents: Aspirin, Clopidogrel

3) By Beta-Adrenergic Blocking Agents: Non-Selective Beta Blockers, Selective Beta Blockers

4) By Calcium Channel Blockers: Dihydropyridine Calcium Channel Blockers, Non-dihydropyridine Calcium Channel Blockers

5) By Anti-Ischemic Agents: Ranolazine, Ivabradine

6) By Statins: Atorvastatin, Rosuvastatin

What Are The Drivers Of The Angina Pectoris Drugs Market?

The increasing prevalence of cardiovascular diseases is expected to propel the growth of the angina pectoris drug market going forward. Cardiovascular diseases encompass a range of disorders that impact the heart and blood vessels, including conditions like coronary artery disease, high blood pressure, heart failure, and stroke. The increasing prevalence of cardiovascular diseases (CVD) can be attributed to several factors, including an aging population, unhealthy lifestyles, and the obesity epidemic. Angina pectoris medications, such as nitrates, beta-blockers, and calcium channel blockers, effectively relieve chest pain and discomfort caused by insufficient blood flow to the heart, thereby enhancing patients' overall quality of life. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024, up 4.0% from 224.4 per 100,000 in 2023. Therefore, the increasing prevalence of cardiovascular diseases is driving the growth of the angina pectoris drug industry.

The increasing rates of diabetes are expected to propel the growth of the angina pectoris drug market in the coming years. Hypertension, sometimes known as high blood pressure, is a medical disorder characterized by excessive arterial blood pressure. Diabetes is a long-term medical disorder marked by high blood glucose (sugar) levels. Diabetes and hypertension are prevalent risk factors for cardiovascular conditions, such as angina pectoris. The rising prevalence of these illnesses increases the demand for angina medicines. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore. The increasing rates of diabetes are driving the angina pectoris drug industry.

Key Players In The Global Angina Pectoris Drugs Market

Major companies operating in the angina pectoris drugs market are Astellas Pharma Inc., Bayer AG, Novartis AG, AstraZeneca PLC, Bausch Health Companies Inc., Merck & Co Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, Sun Pharmaceutical Industries Limited, Sanofi SA, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, AbbVie Inc., Amgen Inc., GlaxoSmithKline plc, Lupin Pharmaceuticals Inc., Merck KGaA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB S.A., Servier Laboratories, Otsuka Pharmaceutical Co. Ltd., Regeneron Pharmaceuticals Inc., Ipsen S.A., H. Lundbeck A/S

Global Angina Pectoris Drugs Market Trends and Insights

Major companies operating in the angina pectoris drug market are focusing on adopting new technologies to sustain their position in the market, such as the U.S. Food and Drug Administration's approval of Labetalol Hydrochloride Injection for treating angina and to better meet the needs of their existing consumers. Nitrostat (Nitroglycerin Sublingual Tablets) has been authorized by the United States Food and Drug Administration (FDA) for the immediate treatment of angina pectoris or the acute prevention of angina pectoris. For instance, in March 2023, Hikma Pharmaceuticals PLC, a UK-based pharmaceutical company, launched Labetalol Hydrochloride Injection, USP, in a prefilled syringe. The Food and Drug Administration of the United States has authorized this product. In hospitals, 10 mg/2 mL PFS is used to treat severe hypertension and lower blood pressure.

Need data on a specific region in this market?

Request Regional Data

Regional Insights

North America was the largest region in the angina pectoris drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Angina Pectoris Drugs Market?

The angina pectoris drugs market consists of sales of aspirin, ranolazine, and angiotensin-converting enzyme inhibitors. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Angina Pectoris Drugs Market Report 2026?

The angina pectoris drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the angina pectoris drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Angina Pectoris Drugs Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$13.63 billion
Revenue Forecast In 2035	$17.67 billion
Growth Rate	CAGR of 5.8% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drugs, Indication, Route of Administration, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Astellas Pharma Inc., Bayer AG, Novartis AG, AstraZeneca PLC, Bausch Health Companies Inc., Merck & Co Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, Sun Pharmaceutical Industries Limited, Sanofi SA, Boehringer Ingelheim International Gmb
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Angina Pectoris Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Angina Pectoris Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Angina Pectoris Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Angina Pectoris Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Artificial Intelligence & Autonomous Intelligence

4.1.2 Biotechnology, Genomics & Precision Medicine

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Personalized Angina Management

4.2.2 Minimally Invasive Drug Delivery Systems

4.2.3 Fixed-Dose Combination Therapies

4.2.4 Growing Geriatric Patient Population

4.2.5 Telemedicine And Remote Cardiac Monitoring

5. Angina Pectoris Drugs Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Homecare

5.3 Specialty Clinics

5.4 Cardiac Centers

5.5 Ambulatory Care Centers

6. Angina Pectoris Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Angina Pectoris Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Angina Pectoris Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Angina Pectoris Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global Angina Pectoris Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Angina Pectoris Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Angina Pectoris Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Angina Pectoris Drugs Market Segmentation

9.1. Global Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins

9.2. Global Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Stable Angina, Unstable Angina, Prinzmetal’s Angina

9.3. Global Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Parenteral, Transdermal, Other Route Of Administrations

9.4. Global Angina Pectoris Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Homecare, Specialty Clinics, Other End Users

9.5. Global Angina Pectoris Drugs Market, Sub-Segmentation Of Nitrates, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Short-Acting Nitrates, Long-Acting Nitrates

9.6. Global Angina Pectoris Drugs Market, Sub-Segmentation Of Antiplatelet Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Aspirin, Clopidogrel

9.7. Global Angina Pectoris Drugs Market, Sub-Segmentation Of Beta-Adrenergic Blocking Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Non-Selective Beta Blockers, Selective Beta Blockers

9.8. Global Angina Pectoris Drugs Market, Sub-Segmentation Of Calcium Channel Blockers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dihydropyridine Calcium Channel Blockers, Non-dihydropyridine Calcium Channel Blockers

9.9. Global Angina Pectoris Drugs Market, Sub-Segmentation Of Anti-Ischemic Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ranolazine, Ivabradine

9.10. Global Angina Pectoris Drugs Market, Sub-Segmentation Of Statins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Atorvastatin, Rosuvastatin

10. Angina Pectoris Drugs Market Regional And Country Analysis

10.1. Global Angina Pectoris Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Angina Pectoris Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Angina Pectoris Drugs Market

11.1. Asia-Pacific Angina Pectoris Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Angina Pectoris Drugs Market

12.1. China Angina Pectoris Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Angina Pectoris Drugs Market

13.1. India Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Angina Pectoris Drugs Market

14.1. Japan Angina Pectoris Drugs Market Overview

14.2. Japan Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Angina Pectoris Drugs Market

15.1. Australia Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Angina Pectoris Drugs Market

16.1. Indonesia Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Angina Pectoris Drugs Market

17.1. South Korea Angina Pectoris Drugs Market Overview

17.2. South Korea Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Angina Pectoris Drugs Market

18.1. Taiwan Angina Pectoris Drugs Market Overview

18.2. Taiwan Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Angina Pectoris Drugs Market

19.1. South East Asia Angina Pectoris Drugs Market Overview

19.2. South East Asia Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Angina Pectoris Drugs Market

20.1. Western Europe Angina Pectoris Drugs Market Overview

20.2. Western Europe Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Angina Pectoris Drugs Market

21.1. UK Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Angina Pectoris Drugs Market

22.1. Germany Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Angina Pectoris Drugs Market

23.1. France Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Angina Pectoris Drugs Market

24.1. Italy Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Angina Pectoris Drugs Market

25.1. Spain Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Angina Pectoris Drugs Market

26.1. Eastern Europe Angina Pectoris Drugs Market Overview

26.2. Eastern Europe Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Angina Pectoris Drugs Market

27.1. Russia Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Angina Pectoris Drugs Market

28.1. North America Angina Pectoris Drugs Market Overview

28.2. North America Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Angina Pectoris Drugs Market

29.1. USA Angina Pectoris Drugs Market Overview

29.2. USA Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Angina Pectoris Drugs Market

30.1. Canada Angina Pectoris Drugs Market Overview

30.2. Canada Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Angina Pectoris Drugs Market

31.1. South America Angina Pectoris Drugs Market Overview

31.2. South America Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Angina Pectoris Drugs Market

32.1. Brazil Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Angina Pectoris Drugs Market

33.1. Middle East Angina Pectoris Drugs Market Overview

33.2. Middle East Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Angina Pectoris Drugs Market

34.1. Africa Angina Pectoris Drugs Market Overview

34.2. Africa Angina Pectoris Drugs Market, Segmentation By Drugs, Segmentation By Indication, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Angina Pectoris Drugs Market Regulatory and Investment Landscape

36. Angina Pectoris Drugs Market Competitive Landscape And Company Profiles

36.1. Angina Pectoris Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Angina Pectoris Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Angina Pectoris Drugs Market Company Profiles

36.3.1. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bausch Health Companies Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Angina Pectoris Drugs Market Other Major And Innovative Companies

Merck & Co Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, Sun Pharmaceutical Industries Limited, Sanofi SA, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, AbbVie Inc., Amgen Inc., GlaxoSmithKline plc, Lupin Pharmaceuticals Inc., Merck KGaA, Takeda Pharmaceutical Company Limited

38. Global Angina Pectoris Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Angina Pectoris Drugs Market

40. Angina Pectoris Drugs Market High Potential Countries, Segments and Strategies

40.1 Angina Pectoris Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 Angina Pectoris Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 Angina Pectoris Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Angina Pectoris Drugs Market, Overview Of Key Products - Product Examples

Table 2: Global Angina Pectoris Drugs Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Angina Pectoris Drugs Market, Supply Chain Analysis

Table 4: Global Angina Pectoris Drugs Market, Major Raw Material Providers

Table 5: Global Angina Pectoris Drugs Market, Major Resource Providers

Table 6: Global Angina Pectoris Drugs Market, Major Manufacturers (Suppliers)

Table 7: Global Angina Pectoris Drugs Market, Major Distributors And Channel Partners

Table 8: Global Angina Pectoris Drugs Market, Key Technologies & Future Trends

Table 9: Global Angina Pectoris Drugs Market, Major Trends

Table 10: Global Angina Pectoris Drugs Market, Major End Users

Table 11: Global Angina Pectoris Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Angina Pectoris Drugs Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Angina Pectoris Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Angina Pectoris Drugs Market - TAM, US$ Billion, 2025

Table 15: Global Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Angina Pectoris Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Nitrates, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Antiplatelet Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Beta-Adrenergic Blocking Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Calcium Channel Blockers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Anti-Ischemic Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Statins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Angina Pectoris Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Global Angina Pectoris Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: Asia-Pacific, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: China, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: India, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Japan, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Australia, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Indonesia, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South Korea, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Taiwan, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: South East Asia, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Western Europe, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: UK, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Germany, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: France, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Italy, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Spain, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Eastern Europe, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: Russia, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: North America, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: USA, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Canada, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: South America, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Brazil, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Middle East, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Africa, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 99: Global Angina Pectoris Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 100: Global Angina Pectoris Drugs Market - Company Scoring Matrix

Table 101: Astellas Pharma Inc. Financial Performance

Table 102: Bayer AG Financial Performance

Table 103: Novartis AG Financial Performance

Table 104: AstraZeneca PLC Financial Performance

Table 105: Bausch Health Companies Inc. Financial Performance

Table 106: Global Angina Pectoris Drugs Market, Competitive Benchmarking (In USD Billions)

Table 107: Global Angina Pectoris Drugs Market, Competitive Dashboard

Table 108: Global Angina Pectoris Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 109: Global, Angina Pectoris Drugs Market Size Gain ($ Billion), Segmentation By Drugs, 2025 – 2030

Table 110: Global, Angina Pectoris Drugs Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Table 111: Global, Angina Pectoris Drugs Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030

List Of Figures

Figure 1: Global Angina Pectoris Drugs Market, Overview Of Key Products - Product Examples

Figure 2: Global Angina Pectoris Drugs Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Angina Pectoris Drugs Market, Supply Chain Analysis

Figure 4: Global Angina Pectoris Drugs Market, Major Raw Material Providers

Figure 5: Global Angina Pectoris Drugs Market, Major Resource Providers

Figure 6: Global Angina Pectoris Drugs Market, Major Manufacturers (Suppliers)

Figure 7: Global Angina Pectoris Drugs Market, Major Distributors And Channel Partners

Figure 8: Global Angina Pectoris Drugs Market, Key Technologies & Future Trends

Figure 9: Global Angina Pectoris Drugs Market, Major Trends

Figure 10: Global Angina Pectoris Drugs Market, Major End Users

Figure 11: Global Angina Pectoris Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Angina Pectoris Drugs Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Angina Pectoris Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Angina Pectoris Drugs Market - TAM, US$ Billion, 2025

Figure 15: Global Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Angina Pectoris Drugs Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Nitrates, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Antiplatelet Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Beta-Adrenergic Blocking Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Calcium Channel Blockers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Anti-Ischemic Agents, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Angina Pectoris Drugs Market, Sub-Segmentation Of Statins, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Angina Pectoris Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Global Angina Pectoris Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: Asia-Pacific, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: China, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: India, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Japan, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Australia, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Indonesia, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South Korea, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Taiwan, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: South East Asia, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Western Europe, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: UK, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Germany, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: France, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Italy, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Spain, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Eastern Europe, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: Russia, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: North America, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: USA, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Canada, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: South America, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Brazil, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Middle East, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Angina Pectoris Drugs Market, Segmentation By Drugs, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Angina Pectoris Drugs Market, Segmentation By Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Africa, Angina Pectoris Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 99: Global Angina Pectoris Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 100: Global Angina Pectoris Drugs Market - Company Scoring Matrix

Figure 101: Astellas Pharma Inc. Financial Performance

Figure 102: Bayer AG Financial Performance

Figure 103: Novartis AG Financial Performance

Figure 104: AstraZeneca PLC Financial Performance

Figure 105: Bausch Health Companies Inc. Financial Performance

Figure 106: Global Angina Pectoris Drugs Market, Competitive Benchmarking (In USD Billions)

Figure 107: Global Angina Pectoris Drugs Market, Competitive Dashboard

Figure 108: Global Angina Pectoris Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 109: Global, Angina Pectoris Drugs Market Size Gain ($ Billion), Segmentation By Drugs, 2025 – 2030

Figure 110: Global, Angina Pectoris Drugs Market Size Gain ($ Billion), Segmentation By Indication, 2025 – 2030

Figure 111: Global, Angina Pectoris Drugs Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030

Competitive and Market Trend Analysis of Gastric Cancer Therapy Industry Through 2029

Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

Key Market Drivers, Trends, and Forecast for the Global Gene-Editing Transfection Chemicals Industry

Outlook for Generic Pharmaceuticals Contract Manufacturing Market: Key Developments and Future Strategies to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Cardiovascular Monitoring And Diagnostic Devices And Equipment Market Report 2026 - Global Outlook – By Product Type (Cardiopulmonary Stress Testing Systems, ECG Data Management Systems, ECG Monitoring Equipment, ECG Str...

Anti-Hypertensive Drugs Market Report 2026 - Global Outlook – By Therapeutics (Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Chann...

Angiotensin Receptor Blockers (ARBs) Market Report 2026 - Global Outlook – By Product (Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan), By Application (Hypertension, Cardiovascular Diseases, Kidney ...

Biopsy Devices Market Report 2026 - Global Outlook – By Product Type (Needle-Based Biopsy Guns, Biopsy Forceps, Biopsy Guidance Systems, Biopsy Needles, Other Products), By Image Guiding Technology (MRI-Guided Biopsy, St...

Angina Pectoris Drugs Market Report 2026 - Global Outlook – By Drugs (Nitrates, Antiplatelet Agents, Beta-adrenergic Blocking Agents, Calcium Channel Blockers, Anti-ischemic Agents, Statins), By Indication (Stable Angina...

Angina Market Report 2026 - Global Outlook – By Type (Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types), By Treatment (Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Ot...

Frequently Asked Questions

How big is the Angina Pectoris Drugs Market?

The Angina Pectoris Drugs market was valued at $12.88 billion in 2025, increased to $13.63 billion in 2026, and is projected to reach $17.67 billion by 2030.

What is the Angina Pectoris Drugs market growth?

The global Angina Pectoris Drugs market is expected to grow at a CAGR of 6.7% from 2026 to 2035 to reach $17.67 billion by 2035.

Who are the key players in Angina Pectoris Drugs market?

Some Key Players in the Angina Pectoris Drugs market Include, Astellas Pharma Inc., Bayer AG, Novartis AG, AstraZeneca PLC, Bausch Health Companies Inc., Merck & Co Inc., Eli Lilly and Company, Pfizer Inc., Abbott Laboratories, Sun Pharmaceutical Industries Limited, Sanofi SA, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, AbbVie Inc., Amgen Inc., GlaxoSmithKline plc, Lupin Pharmaceuticals Inc., Merck KGaA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB S.A., Servier Laboratories, Otsuka Pharmaceutical Co. Ltd., Regeneron Pharmaceuticals Inc., Ipsen S.A., H. Lundbeck A/S .

What is the anticipated growth trend for the Angina Pectoris Drugs market?

Major trend in this market includes: Hikma Pharmaceuticals Unveils Labetalol Hydrochloride Injection, Usp, Marking A Milestone In Angina Pectoris Drug Market. For further insights on this market. request a sample here

Which region has the most growth potential in the Angina Pectoris Drugs market?

North America was the largest region in the angina pectoris drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the angina pectoris drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.